Stockscreener 앱 받기
9.58
3.01%
0.28
시간 외 거래:
9.77
0.19
+1.98%
전일 마감가:
$9.30
열려 있는:
$9.3
하루 거래량:
35,055
Relative Volume:
0.50
시가총액:
$47.81M
수익:
$34.77M
순이익/손실:
$-74.04M
주가수익비율:
-1.1952
EPS:
-8.0157
순현금흐름:
$-79.76M
1주 성능:
-2.04%
1개월 성능:
+23.45%
6개월 성능:
-11.48%
1년 성능:
-78.83%
1일 변동 폭
$9.24
$9.87
1주일 범위
$9.24
$10.64
52주 변동 폭
$5.21
$70.75
Mersana Therapeutics Inc Stock (MRSN) Company Profile
명칭
Mersana Therapeutics Inc
전화
617-498-0020
주소
840 MEMORIAL DRIVE, CAMBRIDGE
MRSN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRSN
Mersana Therapeutics Inc
|
9.58 | 46.41M | 34.77M | -74.04M | -79.76M | -8.0157 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mersana Therapeutics Inc Stock (MRSN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-06 | 개시 | William Blair | Outperform |
| 2024-11-15 | 재개 | Citigroup | Buy |
| 2024-03-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-02-29 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-02-29 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-07-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-07-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-27 | 다운그레이드 | Truist | Buy → Hold |
| 2023-07-27 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-06-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-06-15 | 개시 | Guggenheim | Buy |
| 2023-03-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-20 | 개시 | Citigroup | Buy |
| 2022-11-21 | 개시 | Truist | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-08-30 | 개시 | H.C. Wainwright | Buy |
| 2021-03-31 | 개시 | Credit Suisse | Neutral |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-04-29 | 개시 | BTIG Research | Buy |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-11-14 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-08 | 개시 | Robert W. Baird | Outperform |
| 2018-03-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
모두보기
Mersana Therapeutics Inc 주식(MRSN)의 최신 뉴스
Can Mersana Therapeutics Inc. (0M4) stock stage a strong rebound this quarterJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Can you recover from losses in Mersana Therapeutics Inc.2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Why Mersana Therapeutics Inc. stock could rally in 2025Earnings Miss & Community Supported Trade Ideas - newser.com
Can Mersana Therapeutics Inc. (0M4) stock sustain breakout momentumBond Market & Weekly Momentum Stock Picks - newser.com
How Mersana Therapeutics Inc. stock benefits from global expansion2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
How cyclical is Mersana Therapeutics Inc. (0M4) stock compared to rivals2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Using data filters to optimize entry into Mersana Therapeutics Inc.Weekly Investment Report & Reliable Entry Point Alerts - newser.com
Detecting price anomalies in Mersana Therapeutics Inc. with AIJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Earnings visualization tools for Mersana Therapeutics Inc.Market Trend Report & Capital Protection Trade Alerts - newser.com
How Mersana Therapeutics Inc. (0M4) stock responds to job market shiftsJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Heatmap analysis for Mersana Therapeutics Inc. and competitorsJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
What momentum shifts mean for Mersana Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Price action breakdown for Mersana Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - newser.com
Why Mersana Therapeutics Inc. stock remains a top recommendationTreasury Yields & Proven Capital Preservation Tips - newser.com
How Mersana Therapeutics Inc. (0M4) stock reacts to weak economyTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Mersana Therapeutics Inc. stock ready for a breakoutMarket Performance Recap & Reliable Breakout Forecasts - newser.com
News impact scoring models applied to Mersana Therapeutics Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
Does Mersana Therapeutics Inc. qualify in momentum factor screeningShare Buyback & Free Reliable Trade Execution Plans - newser.com
Should you hold or exit Mersana Therapeutics Inc. now2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-30 02:25:49 - newser.com
Mersana Therapeutics Inc (MRSN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):